Results 11 to 20 of about 14,771 (224)
Medication Overuse Headache [PDF]
Medication-overuse headache (MOH) has been described for almost 100 years and is characterized as a daily or near-daily headache that usually presents in patients with preexisting primary headache disorders who are overusing one or more acute or symptomatic headache medications. This article reviews the diagnosis and management of patients with MOH.The
Louter, M.A. +2 more
+9 more sources
Medication-overuse headache [PDF]
Patients with primary headache disorders who overuse analgesia are at risk for MOH, in which the analgesia leads to the paradoxical effect of increasing headache frequency ([Box 1][1]).[1][2] The prevalence of MOH in the general population is 1%–2% and as high as 20.6% in referrals to ...
Andrew, Micieli, Jennifer, Robblee
+7 more sources
Research progress of medication⁃overuse headache
Medication⁃overuse headache (MOH) is a global public health problem involving medicine, economics and sociology. High frequency or chronic primary headache is a risk factor of MOH. The methods to prevent MOH are to strengthen the treatment and management
CHEN Chun⁃fu
doaj +1 more source
Medication-overuse headache (MOH) can be caused by almost all anti-headache drugs including analgesics, ergots, triptans, and combined preparations The prevalence of chronic daily headache (CDH) appears to be between 2% and 4% in the general population. Current epidemiologic studies suggest that MOH accounts for approximately 50% of these cases.
Lutz, Pageler +2 more
+8 more sources
Background Although headache is a common complaint in younger individuals, it is one of the most common complaints among persons over the age of 50 and is a significant cause of morbidity. As there are differences in the causes and types of headache, the
Mansoureh Togha +8 more
doaj +1 more source
Medication overuse headache (MOH) is defined in the latest ICHD-3 criteria as a secondary headache caused by worsening of a pre-existing headache (usually a primary headache) owing to overuse of one or more attack-aborting or pain-relieving medications. MOH can be debilitating and results from biochemical and functional brain changes induced by certain
Dhruv, Bansal, +2 more
+6 more sources
Predictors of response to erenumab after 12 months of treatment
Objective Erenumab is a monoclonal antibody acting against calcitonin gene‐related peptide receptor and approved for the preventive treatment of chronic migraine.
Carlo Baraldi +4 more
doaj +1 more source
Update on medication-overuse headache and its treatment [PDF]
OPINION STATEMENT: Medication-overuse headache-i.e., a too-frequent consumption of acute headache medications leading to increased headache frequency and reduced effectiveness of acute and preventive treatments-is a serious medical condition whose ...
Giamberardino MA +2 more
core +1 more source
Medication-overuse headache: a widely recognized entity amidst ongoing debate
Medication overuse in primary headache disorders is a worldwide phenomenon and has a role in the chronification of headache disorders. The burden of disease on individuals and societies is significant due to high costs and comorbidities.
Nicolas Vandenbussche +10 more
doaj +1 more source
A Descriptive Review of Medication-Overuse Headache: From Pathophysiology to the Comorbidities
Purpose of review: Medication-overuse headache (MOH) is an important problem worldwide, with different areas of controversy regarding its entity. This article reviews the risk factors, comorbidities, pathophysiology, clinical presentation, effective ...
Srdjan Ljubisavljevic +3 more
doaj +1 more source

